Adoption of healthtech in India has so far been uneven across hospitals and care providers, influenced by infrastructure gaps, workflow integration challenges, and limited economic incentives. While a few billion dollars of private capital has been invested in the sector, large-scale transformative outcomes remain scarce.
However, AI presents a unique opportunity to leapfrog traditional adoption hurdles and reimagine healthcare delivery in India. AI can serve as a catalyst to enhance patient access, experience, clinical quality, and system efficiency.
Historically, healthtech has been treated largely as a cost line item, with investments going into systems such as electronic medical records (EMRs), claims processing, and revenue cycle management. These tools, though necessary, have not always demonstrated a direct link to revenue or quality outcomes. What we are witnessing now is a shift: AI is no longer just a back-end utility. It is fast becoming a strategic, care-enabling asset.
Healthcare providers must start viewing AI as a highly capable, resourceful team member that can expand reach, improve engagement, and augment clinical decision-making. We are excited about the potential of AI in India to democratize healthcare delivery through AI-enabled personal health coaches and health companions, as well as clinical decision support systems.
From a developed markets standpoint, given significant inefficiencies in healthcare expenditure and ongoing shortages of clinical and non-clinical staff, we are excited about the potential for Indian founders to create AI-driven products and services that address critical pain points across hospitals, payers, and pharma/life sciences companies. We are seeing successful applications in revenue cycle management (RCM), specialized diagnostics, drug discovery and commercialization, AI-powered workflow management, and claims processing, among others.
We are excited about leveraging AI to enhance the offshoring of healthcare services to India. India has been a major hub for offshoring various healthcare services from developed countries, including clinical documentation, RCM, sales and marketing, regulatory operations for pharmaceutical and life sciences companies, and claims processing and adjudication for payers. These services can be augmented with generative AI and agentic models, supported by a human-in-the-loop approach.
Indian healthcare-focused technology services companies have been trusted partners for global health systems and pharmaceutical companies for decades, and they are uniquely positioned to capitalize on the AI opportunity.
.png)